SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmis
Biofourmis, which combines AI-based data analytics and biosensors to monitor the progress of medical treatments, has raised funding from one of the world’s most high-profile investors. The digital therapeutics company, which launched in Singapore and is now headquartered in Boston, announced today it closed a $100 million Series C led by SoftBank Vision Fund 2, … Continue reading SoftBank Vision Fund 2 leads $100 million Series C in digital therapeutics company Biofourmis
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed